Endometrial effects of lower doses of conjugated equine estrogens and medroxyprogesterone acetate: two-year substudy results
- 1 November 2003
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 80 (5) , 1234-1240
- https://doi.org/10.1016/s0015-0282(03)01167-1
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Is low-dose hormone replacement therapy for postmenopausal women efficacious and desirable?Climacteric, 2001
- Determinants of long-term hormone replacement therapy and reasons for early discontinuationObstetrics & Gynecology, 2000
- Low-potency oestrogen and risk of endometrial cancer: a case-control studyThe Lancet, 1999
- Risk of Endometrial Cancer in Relation to Use of Low-Dose, Unopposed EstrogensObstetrics & Gynecology, 1998
- Low-Dose Esterified Estrogen TherapyArchives of internal medicine (1960), 1997
- The Comparative Effect on Bone Density, Endometrium, and Lipids of Continuous Hormones as Replacement Therapy (CHART Study)JAMA, 1996
- Effects of Hormone Replacement Therapy on Endometrial Histology in Postmenopausal WomenJAMA, 1996
- Hormone replacement therapy and endometrial cancer risk: A meta-analysisObstetrics & Gynecology, 1995
- Postmenopausal unopposed estrogens characteristics of use in relation to the risk of endometrial carcinomaAnnals of Epidemiology, 1993
- Low-dosage micronized 17ß-estradiol prevents bone loss inpostmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1992